First major study to track Long-Term health after revolutionary cancer treatment
NCT ID NCT07048535
Summary
This study aims to understand the long-term health of young people who survived B-cell acute lymphoblastic leukemia (B-ALL) after receiving CAR T-cell therapy. Researchers will follow 80 survivors who are at least two years past their treatment to check for any late-developing health problems. The study will look at brain function, immune system health, and overall well-being to learn how this powerful treatment affects survivors years later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Jude Children's Research Hospital
RECRUITINGMemphis, Tennessee, 38105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.